M&T Bank’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

M&T Bank’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,000	Closed	-$11K	–	1653
2018 Q2	$11K	Hold	30,000	–	–	﹤0.01%	1511
2018 Q1	$45K	Buy	+30,000	New	+$52.4K	﹤0.01%	1504

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

M&T Bank's ARLZ Position: Q3 2018 in Review

M&T Bank sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 30,000 shares — an estimated $11K sold.

M&T Bank first reported a position in ARLZ in Q1 2018 and held it in 2 quarters. The position peaked at $45K in Q1 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

M&T Bank reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
M&T Bank sold 30,000 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $11K.
M&T Bank first reported a position in Aralez Pharmaceuticals Inc. in Q1 2018 and held it in 2 quarters.
M&T Bank's Aralez Pharmaceuticals Inc. position peaked at $45K in Q1 2018.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on M&T Bank's 13F filing for Q3 2018, filed 9 Nov 2018.